Stay updated on Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Sign up to get notified when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.

Latest updates to the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page
- Check6 days agoChange DetectedThe page now displays revision v3.5.4 instead of v3.5.3, indicating a backend/system update. This change does not alter the study information or content presented to users.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision tag v3.5.3 was added to the page's metadata. The previous revision tag v3.5.2 was removed.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedPage revision updated to v3.5.2; the previous revision v3.5.0 has been removed.SummaryDifference0.1%

- Check63 days agoChange DetectedSite-wide update to version 3.5.0. The study details page content remains unchanged.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check99 days agoChange DetectedThese are generic site maintenance updates and do not affect the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.